Shabir Madhi to Poliovirus Vaccine, Inactivated
                            
                            
                                This is a "connection" page, showing publications Shabir Madhi has written about Poliovirus Vaccine, Inactivated.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            2,367
         
        
        
     
 
    
        
        - 
            Immunogenicity of a combined schedule of trivalent oral and inactivated polio vaccines in South African infants. Expert Rev Vaccines. 2019 07; 18(7):751-754.
            
            
                Score: 0,633
             
- 
            Antibody persistence in pre-school children after hexavalent vaccine infant primary and booster administration. Hum Vaccin Immunother. 2019; 15(3):658-668.
            
            
                Score: 0,617
             
- 
            Review of a new fully liquid, hexavalent vaccine: Hexaxim. Expert Opin Biol Ther. 2013 Apr; 13(4):575-93.
            
            
                Score: 0,409
             
- 
            One-year post-primary antibody persistence and booster immune response to a DTaP-IPV//PRP~T vaccine (Pentaxim) given at 18 - 19 months of age in South African children primed at 6, 10 and 14 weeks of age with the same vaccine. S Afr Med J. 2011 Nov 28; 101(12):879-83.
            
            
                Score: 0,375
             
- 
            Effect of cytomegalovirus infection on humoral immune responses to select vaccines administered during infancy. Vaccine. 2021 08 09; 39(34):4793-4799.
            
            
                Score: 0,183
             
- 
            Antibody persistence and booster vaccination of a fully liquid hexavalent vaccine coadministered with measles/mumps/rubella and varicella vaccines at 15-18 months of age in healthy South African infants. Pediatr Infect Dis J. 2013 Aug; 32(8):889-97.
            
            
                Score: 0,105
             
- 
            Immunogenicity and safety of a hexavalent pediatric vaccine in HIV-exposed infected and uninfected infants in Republic of South Africa. Hum Vaccin Immunother. 2021 06 03; 17(6):1770-1778.
            
            
                Score: 0,044